BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30732491)

  • 1. Novel cystamine-core dendrimer-formulation rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection by augmenting autophagy.
    Faraj J; Bodas M; Pehote G; Swanson D; Sharma A; Vij N
    Expert Opin Drug Deliv; 2019 Feb; 16(2):177-186. PubMed ID: 30732491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.
    Brockman SM; Bodas M; Silverberg D; Sharma A; Vij N
    PLoS One; 2017; 12(9):e0184793. PubMed ID: 28902888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.
    Luciani A; Villella VR; Esposito S; Gavina M; Russo I; Silano M; Guido S; Pettoello-Mantovani M; Carnuccio R; Scholte B; De Matteis A; Maiuri MC; Raia V; Luini A; Kroemer G; Maiuri L
    Autophagy; 2012 Nov; 8(11):1657-72. PubMed ID: 22874563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a rational combination therapy of cystic fibrosis: How cystamine restores the stability of mutant CFTR.
    Villella VR; Esposito S; Maiuri MC; Raia V; Kroemer G; Maiuri L
    Autophagy; 2013 Sep; 9(9):1431-4. PubMed ID: 23800975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases.
    Vij N
    Expert Opin Drug Deliv; 2017 Apr; 14(4):483-489. PubMed ID: 27561233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.
    Moreau-Marquis S; Bomberger JM; Anderson GG; Swiatecka-Urban A; Ye S; O'Toole GA; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L25-37. PubMed ID: 18359885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.
    Suaud L; Miller K; Alvey L; Yan W; Robay A; Kebler C; Kreindler JL; Guttentag S; Hubbard MJ; Rubenstein RC
    J Biol Chem; 2011 Jun; 286(24):21239-53. PubMed ID: 21525008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.
    De Stefano D; Villella VR; Esposito S; Tosco A; Sepe A; De Gregorio F; Salvadori L; Grassia R; Leone CA; De Rosa G; Maiuri MC; Pettoello-Mantovani M; Guido S; Bossi A; Zolin A; Venerando A; Pinna LA; Mehta A; Bona G; Kroemer G; Maiuri L; Raia V
    Autophagy; 2014; 10(11):2053-74. PubMed ID: 25350163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR.
    Zhang S; Stoll G; Pedro JMBS; Sica V; Sauvat A; Obrist F; Kepp O; Li Y; Maiuri L; Zamzami N; Kroemer G
    Cell Death Dis; 2018 Feb; 9(2):191. PubMed ID: 29415993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR).
    Caohuy H; Yang Q; Eudy Y; Ha TA; Xu AE; Glover M; Frizzell RA; Jozwik C; Pollard HB
    J Biol Chem; 2014 Dec; 289(52):35953-68. PubMed ID: 25384981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells?
    Hampton TH; Ballok AE; Bomberger JM; Rutkowski MR; Barnaby R; Coutermarsh B; Conejo-Garcia JR; O'Toole GA; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(6):L509-18. PubMed ID: 22821996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.
    Luciani A; Villella VR; Esposito S; Brunetti-Pierri N; Medina D; Settembre C; Gavina M; Pulze L; Giardino I; Pettoello-Mantovani M; D'Apolito M; Guido S; Masliah E; Spencer B; Quaratino S; Raia V; Ballabio A; Maiuri L
    Nat Cell Biol; 2010 Sep; 12(9):863-75. PubMed ID: 20711182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells.
    Trinh NT; Bilodeau C; Maillé É; Ruffin M; Quintal MC; Desrosiers MY; Rousseau S; Brochiero E
    Eur Respir J; 2015 Jun; 45(6):1590-602. PubMed ID: 25792634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers.
    Rowe SM; Pyle LC; Jurkevante A; Varga K; Collawn J; Sloane PA; Woodworth B; Mazur M; Fulton J; Fan L; Li Y; Fortenberry J; Sorscher EJ; Clancy JP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):268-78. PubMed ID: 20226262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation.
    Ferrari E; Monzani R; Villella VR; Esposito S; Saluzzo F; Rossin F; D'Eletto M; Tosco A; De Gregorio F; Izzo V; Maiuri MC; Kroemer G; Raia V; Maiuri L
    Cell Death Dis; 2017 Jan; 8(1):e2544. PubMed ID: 28079883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A truncated CFTR protein rescues endogenous DeltaF508-CFTR and corrects chloride transport in mice.
    Cormet-Boyaka E; Hong JS; Berdiev BK; Fortenberry JA; Rennolds J; Clancy JP; Benos DJ; Boyaka PN; Sorscher EJ
    FASEB J; 2009 Nov; 23(11):3743-51. PubMed ID: 19620404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
    Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
    Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells.
    Swiatecka-Urban A; Moreau-Marquis S; Maceachran DP; Connolly JP; Stanton CR; Su JR; Barnaby R; O'toole GA; Stanton BA
    Am J Physiol Cell Physiol; 2006 Mar; 290(3):C862-72. PubMed ID: 16236828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.